Ophiopogonin-D T6S1255
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Ophiopogonin D(OPD) significantly inhibited the in vitro and in vivo growth of prostate cells via RIPK1, OPD may be developed as a potential anti-prostate cancer agent.
CAS nr:
41753-55-3
Purity:
98%
Molecular Weight:
855,02
SMILES:
C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC=C5C[C@@H](O)C[C@@H](O[C@@H]6O[C@H](C)[C@H](O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)[C@]5(C)[C@H]4CC[C@]23C)O[C@]11CC[C@@H](C)CO1
Formula:
C44H70O16
Pathway:
Immunology/Inflammation
Target:
ROS
